

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 4.94495800 |
| 2 | cellular response to ATP (GO:0071318) | 4.72252302 |
| 3 | neuronal action potential propagation (GO:0019227) | 4.69856527 |
| 4 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.64865412 |
| 5 | vocalization behavior (GO:0071625) | 4.62525260 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.60884963 |
| 7 | cell migration in hindbrain (GO:0021535) | 4.57261867 |
| 8 | behavioral response to nicotine (GO:0035095) | 4.53070552 |
| 9 | negative regulation of cell aging (GO:0090344) | 4.46553625 |
| 10 | regulation of skeletal muscle contraction (GO:0014819) | 4.45971744 |
| 11 | phosphate ion transport (GO:0006817) | 4.45174355 |
| 12 | glutamate secretion (GO:0014047) | 4.42688167 |
| 13 | phosphate ion transmembrane transport (GO:0035435) | 4.42107392 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.41524848 |
| 15 | protein localization to synapse (GO:0035418) | 4.38288622 |
| 16 | neuromuscular synaptic transmission (GO:0007274) | 4.36024845 |
| 17 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.33230077 |
| 18 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.25061587 |
| 19 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 4.17273051 |
| 20 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 4.17273051 |
| 21 | sensory perception of taste (GO:0050909) | 4.15685063 |
| 22 | negative regulation of microtubule polymerization (GO:0031115) | 4.04396831 |
| 23 | regulation of feeding behavior (GO:0060259) | 4.01510252 |
| 24 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.98667202 |
| 25 | neuronal action potential (GO:0019228) | 3.85872663 |
| 26 | peripheral nervous system neuron development (GO:0048935) | 3.84499335 |
| 27 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.82603997 |
| 28 | detection of light stimulus involved in visual perception (GO:0050908) | 3.82603997 |
| 29 | peristalsis (GO:0030432) | 3.79152558 |
| 30 | cellular potassium ion homeostasis (GO:0030007) | 3.76544592 |
| 31 | synaptic vesicle maturation (GO:0016188) | 3.76401053 |
| 32 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.74770231 |
| 33 | negative regulation of dendrite development (GO:2000171) | 3.72036007 |
| 34 | regulation of synaptic vesicle transport (GO:1902803) | 3.71053996 |
| 35 | detection of temperature stimulus (GO:0016048) | 3.70889997 |
| 36 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.69668996 |
| 37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.69417974 |
| 38 | mitotic cell cycle arrest (GO:0071850) | 3.67772153 |
| 39 | proline transport (GO:0015824) | 3.65990037 |
| 40 | sulfur amino acid catabolic process (GO:0000098) | 3.57460307 |
| 41 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.56463359 |
| 42 | neurotransmitter secretion (GO:0007269) | 3.52234953 |
| 43 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.52226155 |
| 44 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.52226155 |
| 45 | membrane depolarization during action potential (GO:0086010) | 3.50446870 |
| 46 | transepithelial transport (GO:0070633) | 3.49702774 |
| 47 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.48046807 |
| 48 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.47979727 |
| 49 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.45971344 |
| 50 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.45028006 |
| 51 | response to gravity (GO:0009629) | 3.39825871 |
| 52 | adenosine receptor signaling pathway (GO:0001973) | 3.39574623 |
| 53 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.39379352 |
| 54 | neuron-neuron synaptic transmission (GO:0007270) | 3.38758834 |
| 55 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.34910354 |
| 56 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.34113281 |
| 57 | innervation (GO:0060384) | 3.32169484 |
| 58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.31665605 |
| 59 | protein carboxylation (GO:0018214) | 3.31665605 |
| 60 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.31299244 |
| 61 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.31258077 |
| 62 | lens fiber cell differentiation (GO:0070306) | 3.30248321 |
| 63 | GDP-mannose metabolic process (GO:0019673) | 3.30182914 |
| 64 | DNA strand renaturation (GO:0000733) | 3.27867586 |
| 65 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.26102979 |
| 66 | positive regulation of catecholamine secretion (GO:0033605) | 3.19484975 |
| 67 | transferrin transport (GO:0033572) | 3.18735990 |
| 68 | neurofilament cytoskeleton organization (GO:0060052) | 3.16994098 |
| 69 | ATP synthesis coupled proton transport (GO:0015986) | 3.16647095 |
| 70 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.16647095 |
| 71 | synaptic transmission, glutamatergic (GO:0035249) | 3.13371748 |
| 72 | semaphorin-plexin signaling pathway (GO:0071526) | 3.11891682 |
| 73 | protein retention in ER lumen (GO:0006621) | 3.09822008 |
| 74 | cerebellar granule cell differentiation (GO:0021707) | 3.09536204 |
| 75 | glutamate receptor signaling pathway (GO:0007215) | 3.08794729 |
| 76 | positive regulation of synapse maturation (GO:0090129) | 3.08413369 |
| 77 | neuromuscular process controlling posture (GO:0050884) | 3.07353824 |
| 78 | sodium ion export (GO:0071436) | 3.05788655 |
| 79 | neuron recognition (GO:0008038) | 3.02991015 |
| 80 | negative regulation of cation channel activity (GO:2001258) | 3.02948703 |
| 81 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.02425693 |
| 82 | urinary tract smooth muscle contraction (GO:0014848) | 3.00053042 |
| 83 | serotonin receptor signaling pathway (GO:0007210) | 2.99571205 |
| 84 | neurotransmitter transport (GO:0006836) | 2.99127133 |
| 85 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.99087984 |
| 86 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.98135134 |
| 87 | regulation of guanylate cyclase activity (GO:0031282) | 2.96458043 |
| 88 | calcium ion-dependent exocytosis (GO:0017156) | 2.95803686 |
| 89 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.95330445 |
| 90 | retinal ganglion cell axon guidance (GO:0031290) | 2.93753937 |
| 91 | action potential (GO:0001508) | 2.93418934 |
| 92 | membrane hyperpolarization (GO:0060081) | 2.93014322 |
| 93 | ferric iron transport (GO:0015682) | 2.92891235 |
| 94 | trivalent inorganic cation transport (GO:0072512) | 2.92891235 |
| 95 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.92826254 |
| 96 | locomotory exploration behavior (GO:0035641) | 2.92408611 |
| 97 | striatum development (GO:0021756) | 2.92209636 |
| 98 | layer formation in cerebral cortex (GO:0021819) | 2.91845647 |
| 99 | membrane depolarization (GO:0051899) | 2.88083649 |
| 100 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.87487408 |
| 101 | cell communication involved in cardiac conduction (GO:0086065) | 2.86718851 |
| 102 | regulation of vesicle fusion (GO:0031338) | 2.86555989 |
| 103 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.86087869 |
| 104 | nucleotide transmembrane transport (GO:1901679) | 2.85477767 |
| 105 | synaptic vesicle endocytosis (GO:0048488) | 2.85416996 |
| 106 | presynaptic membrane assembly (GO:0097105) | 2.84820177 |
| 107 | acidic amino acid transport (GO:0015800) | 2.82269234 |
| 108 | dopamine receptor signaling pathway (GO:0007212) | 2.81774516 |
| 109 | positive regulation of synapse assembly (GO:0051965) | 2.81729096 |
| 110 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.81490763 |
| 111 | chaperone-mediated protein transport (GO:0072321) | 2.81355673 |
| 112 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.81114149 |
| 113 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.80933256 |
| 114 | regulation of postsynaptic membrane potential (GO:0060078) | 2.80912602 |
| 115 | protein neddylation (GO:0045116) | 2.80543462 |
| 116 | synapse assembly (GO:0007416) | 2.80411012 |
| 117 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.80103399 |
| 118 | exploration behavior (GO:0035640) | 2.79765668 |
| 119 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.78289928 |
| 120 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.78174481 |
| 121 | postsynaptic membrane organization (GO:0001941) | 2.78156081 |
| 122 | regulation of neurotransmitter secretion (GO:0046928) | 2.77350595 |
| 123 | adenine nucleotide transport (GO:0051503) | 2.76793655 |
| 124 | regulation of synapse structural plasticity (GO:0051823) | 2.75671903 |
| 125 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.75210682 |
| 126 | establishment of synaptic vesicle localization (GO:0097480) | 2.74871127 |
| 127 | synaptic vesicle transport (GO:0048489) | 2.74871127 |
| 128 | establishment of mitochondrion localization (GO:0051654) | 2.74181174 |
| 129 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.73959277 |
| 130 | L-glutamate transport (GO:0015813) | 2.73890989 |
| 131 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.73127601 |
| 132 | synaptic transmission (GO:0007268) | 2.72894986 |
| 133 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.72209193 |
| 134 | response to histamine (GO:0034776) | 2.71064637 |
| 135 | presynaptic membrane organization (GO:0097090) | 2.70977639 |
| 136 | regulation of dopamine secretion (GO:0014059) | 2.70835172 |
| 137 | dicarboxylic acid transport (GO:0006835) | 2.70557176 |
| 138 | behavioral response to cocaine (GO:0048148) | 2.70359273 |
| 139 | organelle transport along microtubule (GO:0072384) | 2.70075146 |
| 140 | prepulse inhibition (GO:0060134) | 2.69386094 |
| 141 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.69324179 |
| 142 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.69147396 |
| 143 | establishment of vesicle localization (GO:0051650) | 2.68817550 |
| 144 | regulation of protein kinase A signaling (GO:0010738) | 2.68188304 |
| 145 | ovulation cycle (GO:0042698) | 2.66549058 |
| 146 | regulation of neurotransmitter levels (GO:0001505) | 2.66526212 |
| 147 | positive regulation of heat generation (GO:0031652) | 2.65493493 |
| 148 | regulation of dopamine metabolic process (GO:0042053) | 2.64967352 |
| 149 | regulation of catecholamine metabolic process (GO:0042069) | 2.64967352 |
| 150 | regulation of action potential (GO:0098900) | 2.64022712 |
| 151 | long-term memory (GO:0007616) | 2.63017629 |
| 152 | type B pancreatic cell proliferation (GO:0044342) | 2.62049607 |
| 153 | sodium ion transmembrane transport (GO:0035725) | 2.51827091 |
| 154 | myelin assembly (GO:0032288) | 2.48780570 |
| 155 | mating behavior (GO:0007617) | 2.48366133 |
| 156 | visual learning (GO:0008542) | 2.47902262 |
| 157 | positive regulation of vesicle fusion (GO:0031340) | 2.47638432 |
| 158 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.47355001 |
| 159 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.47355001 |
| 160 | adult feeding behavior (GO:0008343) | 2.47079574 |
| 161 | regulation of ARF protein signal transduction (GO:0032012) | 2.45116966 |
| 162 | behavioral response to pain (GO:0048266) | 2.45001466 |
| 163 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.43753443 |
| 164 | regulation of synaptic plasticity (GO:0048167) | 2.41703524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.18114124 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.61696108 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.13621049 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.96942176 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.95388510 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.91057189 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.76898560 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.71352020 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.63792592 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.58766696 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.56881031 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.56881031 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.55868643 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55822478 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51173488 |
| 16 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.43240360 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.39809621 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.39232874 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.38824670 |
| 20 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.38707321 |
| 21 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36952729 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 2.36784898 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.36643635 |
| 24 | P68_20966046_ChIP-Seq_HELA_Human | 2.32126174 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30330789 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.27052161 |
| 27 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.20403007 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12301221 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.11777541 |
| 30 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 2.09303139 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08973370 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.04916937 |
| 33 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.02499822 |
| 34 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.97885214 |
| 35 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94532601 |
| 36 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.87754452 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.87643051 |
| 38 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.81868487 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81443192 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80065721 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.77884928 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.74644432 |
| 43 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.73640767 |
| 44 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.73367968 |
| 45 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71824187 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.70912573 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.68508652 |
| 48 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.63918332 |
| 49 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.63466497 |
| 50 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.62612310 |
| 51 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.62464798 |
| 52 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.59907056 |
| 53 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.59599768 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57627439 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56695894 |
| 56 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55655857 |
| 57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54521505 |
| 58 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.51845416 |
| 59 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.49610573 |
| 60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49342278 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.48806546 |
| 62 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.46651305 |
| 63 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.46379346 |
| 64 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.46315362 |
| 65 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45709242 |
| 66 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.45350786 |
| 67 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.44337151 |
| 68 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.43639371 |
| 69 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42764073 |
| 70 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.40222448 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39495863 |
| 72 | AR_25329375_ChIP-Seq_VCAP_Human | 1.39204947 |
| 73 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.38707547 |
| 74 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37784160 |
| 75 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.35696179 |
| 76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35060374 |
| 77 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.32964753 |
| 78 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.32442223 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31608149 |
| 80 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.31139850 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30557328 |
| 82 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.30546855 |
| 83 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.30504318 |
| 84 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.29507220 |
| 85 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29264058 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.28960219 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28619328 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27066565 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25662022 |
| 90 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25224078 |
| 91 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24343917 |
| 92 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.24176873 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23980981 |
| 94 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22255746 |
| 95 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.21517045 |
| 96 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.21338555 |
| 97 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21079929 |
| 98 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.20438769 |
| 99 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.18740027 |
| 100 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18608955 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17696903 |
| 102 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.14274757 |
| 103 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.13903086 |
| 104 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12701537 |
| 105 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12575459 |
| 106 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.12482471 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11980009 |
| 108 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.11462649 |
| 109 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11414048 |
| 110 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11255434 |
| 111 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10971987 |
| 112 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09454160 |
| 113 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.09076713 |
| 114 | MAF_26560356_Chip-Seq_TH2_Human | 1.08702583 |
| 115 | ERA_21632823_ChIP-Seq_H3396_Human | 1.07904055 |
| 116 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07518519 |
| 117 | JUN_21703547_ChIP-Seq_K562_Human | 1.06573386 |
| 118 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05658925 |
| 119 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05333416 |
| 120 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05100165 |
| 121 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05100165 |
| 122 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.04207160 |
| 123 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03059327 |
| 124 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02486589 |
| 125 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.02245838 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01711018 |
| 127 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.01543661 |
| 128 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00432355 |
| 129 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00388829 |
| 130 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00377910 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00310314 |
| 132 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99910398 |
| 133 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.99848953 |
| 134 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99778121 |
| 135 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96954142 |
| 136 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96655797 |
| 137 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.96614448 |
| 138 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95647248 |
| 139 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.95575123 |
| 140 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94468742 |
| 141 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.94150728 |
| 142 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93877279 |
| 143 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.93347738 |
| 144 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92540541 |
| 145 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92115671 |
| 146 | FUS_26573619_Chip-Seq_HEK293_Human | 0.92054132 |
| 147 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91845785 |
| 148 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90969222 |
| 149 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.90690162 |
| 150 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.90627866 |
| 151 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.88897294 |
| 152 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.88669645 |
| 153 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88020883 |
| 154 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.87719328 |
| 155 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87177531 |
| 156 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86392060 |
| 157 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.86322100 |
| 158 | AR_19668381_ChIP-Seq_PC3_Human | 0.85798536 |
| 159 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.85466819 |
| 160 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84773525 |
| 161 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.83229698 |
| 162 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83082277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001968_abnormal_touch/_nociception | 4.96848036 |
| 2 | MP0002735_abnormal_chemical_nociception | 4.90158127 |
| 3 | MP0004270_analgesia | 4.32721666 |
| 4 | MP0002736_abnormal_nociception_after | 4.30719935 |
| 5 | MP0003880_abnormal_central_pattern | 4.08890091 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 4.06030042 |
| 7 | MP0005171_absent_coat_pigmentation | 3.65563973 |
| 8 | MP0002734_abnormal_mechanical_nocicepti | 3.46699690 |
| 9 | MP0006276_abnormal_autonomic_nervous | 3.33778364 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 3.19008802 |
| 11 | MP0002733_abnormal_thermal_nociception | 3.13766827 |
| 12 | MP0001986_abnormal_taste_sensitivity | 2.82774388 |
| 13 | MP0001970_abnormal_pain_threshold | 2.79082061 |
| 14 | MP0004858_abnormal_nervous_system | 2.74517502 |
| 15 | MP0009745_abnormal_behavioral_response | 2.72791764 |
| 16 | MP0005174_abnormal_tail_pigmentation | 2.68468294 |
| 17 | MP0002063_abnormal_learning/memory/cond | 2.59160334 |
| 18 | MP0002064_seizures | 2.58383579 |
| 19 | MP0002272_abnormal_nervous_system | 2.56748955 |
| 20 | MP0009046_muscle_twitch | 2.49080231 |
| 21 | MP0002160_abnormal_reproductive_system | 2.48052901 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 2.36258030 |
| 23 | MP0002184_abnormal_innervation | 2.22165190 |
| 24 | MP0002067_abnormal_sensory_capabilities | 2.17291729 |
| 25 | MP0002638_abnormal_pupillary_reflex | 2.06129540 |
| 26 | MP0001440_abnormal_grooming_behavior | 2.00469467 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.92344315 |
| 28 | MP0001756_abnormal_urination | 1.91387267 |
| 29 | MP0001661_extended_life_span | 1.88563869 |
| 30 | MP0006292_abnormal_olfactory_placode | 1.85150251 |
| 31 | MP0001486_abnormal_startle_reflex | 1.80357649 |
| 32 | MP0001529_abnormal_vocalization | 1.76337554 |
| 33 | MP0005423_abnormal_somatic_nervous | 1.75412709 |
| 34 | MP0003136_yellow_coat_color | 1.72725997 |
| 35 | MP0002822_catalepsy | 1.72138169 |
| 36 | MP0000778_abnormal_nervous_system | 1.69045257 |
| 37 | MP0001984_abnormal_olfaction | 1.64255003 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.60135980 |
| 39 | MP0005377_hearing/vestibular/ear_phenot | 1.57956180 |
| 40 | MP0003878_abnormal_ear_physiology | 1.57956180 |
| 41 | MP0003941_abnormal_skin_development | 1.57531406 |
| 42 | MP0003329_amyloid_beta_deposits | 1.54524945 |
| 43 | MP0004924_abnormal_behavior | 1.51250371 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.51250371 |
| 45 | MP0000955_abnormal_spinal_cord | 1.47231516 |
| 46 | MP0002557_abnormal_social/conspecific_i | 1.45641064 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.44469271 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.42902442 |
| 49 | MP0000751_myopathy | 1.42568086 |
| 50 | MP0001188_hyperpigmentation | 1.42506054 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.39919582 |
| 52 | MP0003879_abnormal_hair_cell | 1.39881678 |
| 53 | MP0009379_abnormal_foot_pigmentation | 1.39030406 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.35632821 |
| 55 | MP0003122_maternal_imprinting | 1.35461873 |
| 56 | MP0008004_abnormal_stomach_pH | 1.34037934 |
| 57 | MP0002751_abnormal_autonomic_nervous | 1.30591354 |
| 58 | MP0004133_heterotaxia | 1.30566234 |
| 59 | MP0004142_abnormal_muscle_tone | 1.28022081 |
| 60 | MP0001905_abnormal_dopamine_level | 1.24746021 |
| 61 | MP0001664_abnormal_digestion | 1.24113881 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 1.23327464 |
| 63 | MP0002909_abnormal_adrenal_gland | 1.18804103 |
| 64 | MP0002066_abnormal_motor_capabilities/c | 1.18525975 |
| 65 | MP0001485_abnormal_pinna_reflex | 1.16638569 |
| 66 | MP0004885_abnormal_endolymph | 1.14615439 |
| 67 | MP0004019_abnormal_vitamin_homeostasis | 1.11826527 |
| 68 | MP0002876_abnormal_thyroid_physiology | 1.09746640 |
| 69 | MP0009780_abnormal_chondrocyte_physiolo | 1.08136558 |
| 70 | MP0010386_abnormal_urinary_bladder | 1.07515225 |
| 71 | MP0008569_lethality_at_weaning | 1.07246994 |
| 72 | MP0004130_abnormal_muscle_cell | 1.00168686 |
| 73 | MP0005389_reproductive_system_phenotype | 0.97391892 |
| 74 | MP0000538_abnormal_urinary_bladder | 0.97260305 |
| 75 | MP0008260_abnormal_autophagy | 0.96971030 |
| 76 | MP0008872_abnormal_physiological_respon | 0.93123048 |
| 77 | MP0002752_abnormal_somatic_nervous | 0.92161255 |
| 78 | MP0002229_neurodegeneration | 0.91992561 |
| 79 | MP0000537_abnormal_urethra_morphology | 0.90906324 |
| 80 | MP0005646_abnormal_pituitary_gland | 0.86951837 |
| 81 | MP0004085_abnormal_heartbeat | 0.86476154 |
| 82 | MP0000003_abnormal_adipose_tissue | 0.85584465 |
| 83 | MP0000383_abnormal_hair_follicle | 0.85067501 |
| 84 | MP0001346_abnormal_lacrimal_gland | 0.84338595 |
| 85 | MP0004484_altered_response_of | 0.83854318 |
| 86 | MP0005501_abnormal_skin_physiology | 0.83318496 |
| 87 | MP0004742_abnormal_vestibular_system | 0.82664964 |
| 88 | MP0005410_abnormal_fertilization | 0.80509461 |
| 89 | MP0008874_decreased_physiological_sensi | 0.79931000 |
| 90 | MP0001963_abnormal_hearing_physiology | 0.79461275 |
| 91 | MP0002163_abnormal_gland_morphology | 0.79449906 |
| 92 | MP0004043_abnormal_pH_regulation | 0.78914045 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 0.78611504 |
| 94 | MP0002069_abnormal_eating/drinking_beha | 0.78231981 |
| 95 | MP0002152_abnormal_brain_morphology | 0.77617142 |
| 96 | MP0001502_abnormal_circadian_rhythm | 0.76541308 |
| 97 | MP0004215_abnormal_myocardial_fiber | 0.74284905 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.74049404 |
| 99 | MP0005083_abnormal_biliary_tract | 0.73050007 |
| 100 | MP0005645_abnormal_hypothalamus_physiol | 0.71067427 |
| 101 | MP0003633_abnormal_nervous_system | 0.70769760 |
| 102 | MP0005330_cardiomyopathy | 0.70159197 |
| 103 | MP0005332_abnormal_amino_acid | 0.69752521 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.68486105 |
| 105 | MP0005394_taste/olfaction_phenotype | 0.68456568 |
| 106 | MP0005499_abnormal_olfactory_system | 0.68456568 |
| 107 | MP0001348_abnormal_lacrimal_gland | 0.67948994 |
| 108 | MP0003119_abnormal_digestive_system | 0.67320000 |
| 109 | MP0005535_abnormal_body_temperature | 0.66829640 |
| 110 | MP0000534_abnormal_ureter_morphology | 0.65724751 |
| 111 | MP0003631_nervous_system_phenotype | 0.65715380 |
| 112 | MP0006035_abnormal_mitochondrial_morpho | 0.65486581 |
| 113 | MP0003634_abnormal_glial_cell | 0.65380371 |
| 114 | MP0003787_abnormal_imprinting | 0.61413792 |
| 115 | MP0000358_abnormal_cell_content/ | 0.61343576 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 0.61086301 |
| 117 | MP0000747_muscle_weakness | 0.60770466 |
| 118 | MP0000427_abnormal_hair_cycle | 0.60651914 |
| 119 | MP0000470_abnormal_stomach_morphology | 0.59822144 |
| 120 | MP0010678_abnormal_skin_adnexa | 0.59572963 |
| 121 | MP0000604_amyloidosis | 0.58686833 |
| 122 | MP0000750_abnormal_muscle_regeneration | 0.58148188 |
| 123 | MP0010771_integument_phenotype | 0.55245107 |
| 124 | MP0001943_abnormal_respiration | 0.55083193 |
| 125 | MP0003137_abnormal_impulse_conducting | 0.54501070 |
| 126 | MP0002653_abnormal_ependyma_morphology | 0.54297423 |
| 127 | MP0005409_darkened_coat_color | 0.53310533 |
| 128 | MP0000026_abnormal_inner_ear | 0.52341958 |
| 129 | MP0004147_increased_porphyrin_level | 0.51357632 |
| 130 | MP0001270_distended_abdomen | 0.50607653 |
| 131 | MP0001765_abnormal_ion_homeostasis | 0.49593097 |
| 132 | MP0002332_abnormal_exercise_endurance | 0.48977272 |
| 133 | MP0000631_abnormal_neuroendocrine_gland | 0.48310653 |
| 134 | MP0000013_abnormal_adipose_tissue | 0.47128873 |
| 135 | MP0003646_muscle_fatigue | 0.45514690 |
| 136 | MP0000230_abnormal_systemic_arterial | 0.44882657 |
| 137 | MP0003315_abnormal_perineum_morphology | 0.44810837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.26025468 |
| 2 | Focal motor seizures (HP:0011153) | 6.17205968 |
| 3 | Testicular atrophy (HP:0000029) | 6.04798122 |
| 4 | Rib fusion (HP:0000902) | 5.68466261 |
| 5 | Atonic seizures (HP:0010819) | 5.18993713 |
| 6 | Focal seizures (HP:0007359) | 4.83811533 |
| 7 | Febrile seizures (HP:0002373) | 4.78481414 |
| 8 | Poikiloderma (HP:0001029) | 4.68314741 |
| 9 | Attenuation of retinal blood vessels (HP:0007843) | 4.64109207 |
| 10 | Akinesia (HP:0002304) | 4.58451587 |
| 11 | Rectal fistula (HP:0100590) | 4.53010250 |
| 12 | Rectovaginal fistula (HP:0000143) | 4.53010250 |
| 13 | Annular pancreas (HP:0001734) | 4.37099189 |
| 14 | Vaginal fistula (HP:0004320) | 4.27037743 |
| 15 | Intestinal fistula (HP:0100819) | 4.17456162 |
| 16 | Ulnar claw (HP:0001178) | 4.12132209 |
| 17 | Insidious onset (HP:0003587) | 4.06785052 |
| 18 | Termporal pattern (HP:0011008) | 4.06785052 |
| 19 | Pheochromocytoma (HP:0002666) | 3.98284678 |
| 20 | Dyschromatopsia (HP:0007641) | 3.97674234 |
| 21 | Absence seizures (HP:0002121) | 3.96381443 |
| 22 | Mesangial abnormality (HP:0001966) | 3.91772450 |
| 23 | Epileptic encephalopathy (HP:0200134) | 3.90750430 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 3.83538482 |
| 25 | Ulnar bowing (HP:0003031) | 3.81572763 |
| 26 | Neuroendocrine neoplasm (HP:0100634) | 3.80416661 |
| 27 | Popliteal pterygium (HP:0009756) | 3.77540268 |
| 28 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.67465385 |
| 29 | Choroideremia (HP:0001139) | 3.65187354 |
| 30 | Turricephaly (HP:0000262) | 3.58063520 |
| 31 | Dialeptic seizures (HP:0011146) | 3.53804977 |
| 32 | Aplasia of the musculature (HP:0100854) | 3.50858985 |
| 33 | Visual hallucinations (HP:0002367) | 3.50161099 |
| 34 | Action tremor (HP:0002345) | 3.49055940 |
| 35 | Genetic anticipation (HP:0003743) | 3.48780639 |
| 36 | Coronal craniosynostosis (HP:0004440) | 3.43457777 |
| 37 | Increased hepatocellular lipid droplets (HP:0006565) | 3.39816176 |
| 38 | Lipid accumulation in hepatocytes (HP:0006561) | 3.31523967 |
| 39 | Congenital stationary night blindness (HP:0007642) | 3.26289519 |
| 40 | Impaired pain sensation (HP:0007328) | 3.24065550 |
| 41 | Abnormality of pain sensation (HP:0010832) | 3.24065550 |
| 42 | Abnormality of the intrinsic pathway (HP:0010989) | 3.22996258 |
| 43 | Acute necrotizing encephalopathy (HP:0006965) | 3.18224793 |
| 44 | Limb dystonia (HP:0002451) | 3.10662221 |
| 45 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 3.10089968 |
| 46 | Short chin (HP:0000331) | 3.07799502 |
| 47 | Generalized tonic-clonic seizures (HP:0002069) | 3.07097982 |
| 48 | Chronic hepatic failure (HP:0100626) | 3.04129015 |
| 49 | Neonatal onset (HP:0003623) | 3.00238886 |
| 50 | Facial diplegia (HP:0001349) | 2.98101713 |
| 51 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.98031678 |
| 52 | Renal Fanconi syndrome (HP:0001994) | 2.97490557 |
| 53 | Hyperventilation (HP:0002883) | 2.97141435 |
| 54 | Abnormal hair whorl (HP:0010721) | 2.94279629 |
| 55 | Amblyopia (HP:0000646) | 2.92706215 |
| 56 | Decreased central vision (HP:0007663) | 2.92185754 |
| 57 | Thin bony cortex (HP:0002753) | 2.91908321 |
| 58 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.91174159 |
| 59 | Chorioretinal atrophy (HP:0000533) | 2.90778023 |
| 60 | Failure to thrive in infancy (HP:0001531) | 2.89672218 |
| 61 | Ankle clonus (HP:0011448) | 2.88235307 |
| 62 | Abnormality of the vocal cords (HP:0008777) | 2.82438771 |
| 63 | Progressive macrocephaly (HP:0004481) | 2.82199054 |
| 64 | Progressive inability to walk (HP:0002505) | 2.79115750 |
| 65 | Hypothermia (HP:0002045) | 2.78158219 |
| 66 | Amniotic constriction ring (HP:0009775) | 2.68093944 |
| 67 | Abnormality of placental membranes (HP:0011409) | 2.68093944 |
| 68 | Hypoplasia of the brainstem (HP:0002365) | 2.62085106 |
| 69 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.62085106 |
| 70 | Diminished movement (HP:0002374) | 2.54513093 |
| 71 | Mitochondrial inheritance (HP:0001427) | 2.53560412 |
| 72 | Choanal stenosis (HP:0000452) | 2.52837743 |
| 73 | Dysautonomia (HP:0002459) | 2.52007694 |
| 74 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.51608936 |
| 75 | Increased serum pyruvate (HP:0003542) | 2.48615921 |
| 76 | Abnormality of glycolysis (HP:0004366) | 2.48615921 |
| 77 | Truncal ataxia (HP:0002078) | 2.47512339 |
| 78 | Myotonia (HP:0002486) | 2.45820133 |
| 79 | Polyphagia (HP:0002591) | 2.45205652 |
| 80 | Urinary urgency (HP:0000012) | 2.41478823 |
| 81 | Short humerus (HP:0005792) | 2.41430194 |
| 82 | Anteriorly placed anus (HP:0001545) | 2.41217239 |
| 83 | Prolonged partial thromboplastin time (HP:0003645) | 2.40908265 |
| 84 | Acute encephalopathy (HP:0006846) | 2.39713423 |
| 85 | Abnormal eating behavior (HP:0100738) | 2.39697865 |
| 86 | Facial hemangioma (HP:0000329) | 2.39474528 |
| 87 | Hemorrhage of the eye (HP:0011885) | 2.39297989 |
| 88 | Joint hemorrhage (HP:0005261) | 2.38857948 |
| 89 | Hypoventilation (HP:0002791) | 2.36577636 |
| 90 | Supranuclear gaze palsy (HP:0000605) | 2.35607533 |
| 91 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.34879536 |
| 92 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.30484694 |
| 93 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.29860392 |
| 94 | Mutism (HP:0002300) | 2.27417317 |
| 95 | Abnormal albumin level (HP:0012116) | 2.26862597 |
| 96 | Hypoalbuminemia (HP:0003073) | 2.26862597 |
| 97 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.26224189 |
| 98 | Atrioventricular block (HP:0001678) | 2.24679531 |
| 99 | Abnormality of the corticospinal tract (HP:0002492) | 2.22944474 |
| 100 | Inability to walk (HP:0002540) | 2.22664443 |
| 101 | Patellar aplasia (HP:0006443) | 2.21682825 |
| 102 | Autoamputation (HP:0001218) | 2.20070380 |
| 103 | Increased CSF lactate (HP:0002490) | 2.19587834 |
| 104 | Poor suck (HP:0002033) | 2.19251895 |
| 105 | Abnormal social behavior (HP:0012433) | 2.16439172 |
| 106 | Impaired social interactions (HP:0000735) | 2.16439172 |
| 107 | Poor eye contact (HP:0000817) | 2.16135752 |
| 108 | Postural tremor (HP:0002174) | 2.15170981 |
| 109 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.12216402 |
| 110 | Dyskinesia (HP:0100660) | 2.12208399 |
| 111 | Abnormality of magnesium homeostasis (HP:0004921) | 2.12099496 |
| 112 | Broad-based gait (HP:0002136) | 2.11661060 |
| 113 | Bowing of the arm (HP:0006488) | 2.11571753 |
| 114 | Bowed forearm bones (HP:0003956) | 2.11571753 |
| 115 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.11099496 |
| 116 | Oligomenorrhea (HP:0000876) | 2.09653901 |
| 117 | Vertebral arch anomaly (HP:0008438) | 2.08863875 |
| 118 | Long clavicles (HP:0000890) | 2.07043789 |
| 119 | Hypomagnesemia (HP:0002917) | 2.06716776 |
| 120 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.06266598 |
| 121 | Hepatocellular necrosis (HP:0001404) | 2.06216127 |
| 122 | Fused cervical vertebrae (HP:0002949) | 2.05155491 |
| 123 | Esotropia (HP:0000565) | 2.05115601 |
| 124 | Hyperthyroidism (HP:0000836) | 2.00596097 |
| 125 | Exotropia (HP:0000577) | 2.00567854 |
| 126 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.00288212 |
| 127 | Steppage gait (HP:0003376) | 2.00240864 |
| 128 | Specific learning disability (HP:0001328) | 1.98967880 |
| 129 | Abnormal urine phosphate concentration (HP:0012599) | 1.98917505 |
| 130 | Gaze-evoked nystagmus (HP:0000640) | 1.97860651 |
| 131 | Torticollis (HP:0000473) | 1.97221783 |
| 132 | Status epilepticus (HP:0002133) | 1.96903533 |
| 133 | Gait imbalance (HP:0002141) | 1.95619593 |
| 134 | Spastic gait (HP:0002064) | 1.95375091 |
| 135 | Anxiety (HP:0000739) | 1.95126445 |
| 136 | Squamous cell carcinoma (HP:0002860) | 1.94365971 |
| 137 | Abnormality of renal resorption (HP:0011038) | 1.91779467 |
| 138 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.91552419 |
| 139 | Genital tract atresia (HP:0001827) | 1.90479139 |
| 140 | Bradycardia (HP:0001662) | 1.89854604 |
| 141 | Focal dystonia (HP:0004373) | 1.89596304 |
| 142 | Neonatal respiratory distress (HP:0002643) | 1.89314391 |
| 143 | Enlarged epiphyses (HP:0010580) | 1.88318117 |
| 144 | Optic disc pallor (HP:0000543) | 1.88143075 |
| 145 | Craniofacial dystonia (HP:0012179) | 1.88015655 |
| 146 | Mask-like facies (HP:0000298) | 1.87673268 |
| 147 | Depression (HP:0000716) | 1.86788632 |
| 148 | Rapidly progressive (HP:0003678) | 1.86083163 |
| 149 | Pendular nystagmus (HP:0012043) | 1.85606626 |
| 150 | Increased number of teeth (HP:0011069) | 1.83665198 |
| 151 | Ventricular fibrillation (HP:0001663) | 1.83079474 |
| 152 | Epileptiform EEG discharges (HP:0011182) | 1.81870303 |
| 153 | Cerebral hypomyelination (HP:0006808) | 1.81831494 |
| 154 | Bradykinesia (HP:0002067) | 1.81385695 |
| 155 | Vaginal atresia (HP:0000148) | 1.81058172 |
| 156 | Increased muscle lipid content (HP:0009058) | 1.80830936 |
| 157 | Narrow nasal bridge (HP:0000446) | 1.80589649 |
| 158 | Exertional dyspnea (HP:0002875) | 1.80271876 |
| 159 | Dysdiadochokinesis (HP:0002075) | 1.79814167 |
| 160 | Psychosis (HP:0000709) | 1.79723380 |
| 161 | Foot dorsiflexor weakness (HP:0009027) | 1.79582877 |
| 162 | Delusions (HP:0000746) | 1.79189043 |
| 163 | Increased intramyocellular lipid droplets (HP:0012240) | 1.79117877 |
| 164 | Abnormal gallbladder physiology (HP:0012438) | 1.78685677 |
| 165 | Cholecystitis (HP:0001082) | 1.78685677 |
| 166 | Lower limb muscle weakness (HP:0007340) | 1.78576514 |
| 167 | Emotional lability (HP:0000712) | 1.78520492 |
| 168 | X-linked dominant inheritance (HP:0001423) | 1.77712972 |
| 169 | EEG with generalized epileptiform discharges (HP:0011198) | 1.75635164 |
| 170 | Spastic tetraplegia (HP:0002510) | 1.74233813 |
| 171 | Fetal akinesia sequence (HP:0001989) | 1.73582629 |
| 172 | Hammertoe (HP:0001765) | 1.72530798 |
| 173 | Resting tremor (HP:0002322) | 1.72380938 |
| 174 | Abnormality of the costochondral junction (HP:0000919) | 1.71897606 |
| 175 | Delayed epiphyseal ossification (HP:0002663) | 1.69626195 |
| 176 | Cystic hygroma (HP:0000476) | 1.69208689 |
| 177 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.68502869 |
| 178 | Malignant hyperthermia (HP:0002047) | 1.67023868 |
| 179 | Heart block (HP:0012722) | 1.66134239 |
| 180 | Renal tubular dysfunction (HP:0000124) | 1.66096272 |
| 181 | Hypophosphatemic rickets (HP:0004912) | 1.65921839 |
| 182 | Pterygium (HP:0001059) | 1.63081820 |
| 183 | Zonular cataract (HP:0010920) | 1.63067269 |
| 184 | Epiphyseal stippling (HP:0010655) | 1.62014534 |
| 185 | Scanning speech (HP:0002168) | 1.61193446 |
| 186 | Impaired smooth pursuit (HP:0007772) | 1.59107616 |
| 187 | Basal cell carcinoma (HP:0002671) | 1.58445207 |
| 188 | Capillary hemangiomas (HP:0005306) | 1.57508067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 6.02736668 |
| 2 | CASK | 3.84140819 |
| 3 | MAP3K12 | 3.75788892 |
| 4 | NTRK3 | 3.53436323 |
| 5 | MAP3K9 | 3.31498047 |
| 6 | MINK1 | 2.84874290 |
| 7 | GRK5 | 2.62838052 |
| 8 | NTRK1 | 2.55576549 |
| 9 | MAP3K4 | 2.54057103 |
| 10 | MAP2K7 | 2.52934397 |
| 11 | MARK1 | 2.46042089 |
| 12 | EPHA2 | 2.32646331 |
| 13 | KSR2 | 2.28663628 |
| 14 | ARAF | 2.23484713 |
| 15 | RIPK4 | 2.17677396 |
| 16 | EPHA4 | 1.97594956 |
| 17 | SIK3 | 1.95688087 |
| 18 | DAPK2 | 1.95353971 |
| 19 | MAP2K4 | 1.94777760 |
| 20 | MAP3K2 | 1.87767990 |
| 21 | LIMK1 | 1.77637260 |
| 22 | MAPK13 | 1.69924374 |
| 23 | MUSK | 1.68172362 |
| 24 | DAPK1 | 1.67459658 |
| 25 | NTRK2 | 1.64683753 |
| 26 | NME1 | 1.61617908 |
| 27 | LMTK2 | 1.45242341 |
| 28 | MAPKAPK3 | 1.42387101 |
| 29 | KSR1 | 1.33518092 |
| 30 | LATS2 | 1.28601040 |
| 31 | BCR | 1.27085653 |
| 32 | PLK2 | 1.24089700 |
| 33 | CDK5 | 1.20550285 |
| 34 | WNK1 | 1.19666474 |
| 35 | BUB1 | 1.16042349 |
| 36 | PNCK | 1.12936602 |
| 37 | MST4 | 1.10259765 |
| 38 | MAP4K2 | 1.07687506 |
| 39 | RET | 1.07347500 |
| 40 | TESK2 | 1.06017079 |
| 41 | PAK6 | 1.05717896 |
| 42 | FER | 1.02593429 |
| 43 | PDK3 | 1.01085950 |
| 44 | PDK4 | 1.01085950 |
| 45 | BMPR1B | 1.00767746 |
| 46 | MATK | 1.00028262 |
| 47 | UHMK1 | 1.00004432 |
| 48 | STK38 | 0.99550566 |
| 49 | MAP2K1 | 0.98968768 |
| 50 | PTK2B | 0.98806371 |
| 51 | CDK19 | 0.97798519 |
| 52 | PHKG1 | 0.96772799 |
| 53 | PHKG2 | 0.96772799 |
| 54 | TRIM28 | 0.96413605 |
| 55 | AKT3 | 0.96141995 |
| 56 | SGK223 | 0.93825508 |
| 57 | SGK494 | 0.93825508 |
| 58 | PRKCG | 0.93447871 |
| 59 | SIK2 | 0.93293851 |
| 60 | CDK14 | 0.92645315 |
| 61 | CAMK2A | 0.86950519 |
| 62 | DDR2 | 0.86142363 |
| 63 | TNIK | 0.85031738 |
| 64 | BRD4 | 0.83221151 |
| 65 | CDK18 | 0.82959055 |
| 66 | PRKD2 | 0.82783646 |
| 67 | CAMKK2 | 0.82696213 |
| 68 | PRKCE | 0.82052942 |
| 69 | ERBB4 | 0.82052754 |
| 70 | DYRK1B | 0.81007085 |
| 71 | CAMK2B | 0.80451349 |
| 72 | PRKD3 | 0.78934023 |
| 73 | WNK3 | 0.75848842 |
| 74 | BRAF | 0.75575792 |
| 75 | MARK2 | 0.75150738 |
| 76 | PAK1 | 0.74670247 |
| 77 | TSSK6 | 0.74445617 |
| 78 | SGK2 | 0.73979250 |
| 79 | OXSR1 | 0.71252575 |
| 80 | ADRBK1 | 0.71126379 |
| 81 | MYLK | 0.70951906 |
| 82 | CDK15 | 0.70568266 |
| 83 | CAMK2D | 0.70556886 |
| 84 | NEK1 | 0.70437684 |
| 85 | RPS6KA2 | 0.67968009 |
| 86 | STK11 | 0.67967982 |
| 87 | PDPK1 | 0.67740292 |
| 88 | PINK1 | 0.67321555 |
| 89 | MAP3K1 | 0.67024856 |
| 90 | LATS1 | 0.66183597 |
| 91 | PTK2 | 0.65439303 |
| 92 | MET | 0.64229568 |
| 93 | CDK11A | 0.61886108 |
| 94 | CDK6 | 0.61551327 |
| 95 | RIPK1 | 0.59631673 |
| 96 | AURKA | 0.59242293 |
| 97 | DYRK2 | 0.55385662 |
| 98 | IRAK2 | 0.55231130 |
| 99 | GRK7 | 0.54210794 |
| 100 | ACVR1B | 0.53643402 |
| 101 | FES | 0.53000108 |
| 102 | CAMKK1 | 0.52663981 |
| 103 | MAPK10 | 0.52270450 |
| 104 | PAK3 | 0.50475507 |
| 105 | CAMK2G | 0.50425420 |
| 106 | SGK1 | 0.50117486 |
| 107 | NEK6 | 0.49739451 |
| 108 | WNK4 | 0.49451960 |
| 109 | BRSK1 | 0.49123266 |
| 110 | CAMK1D | 0.49069672 |
| 111 | PRPF4B | 0.47981081 |
| 112 | CSNK1G2 | 0.47928138 |
| 113 | CAMK4 | 0.47225035 |
| 114 | STK39 | 0.46282559 |
| 115 | PBK | 0.45813942 |
| 116 | PRKCI | 0.45502271 |
| 117 | CCNB1 | 0.45433588 |
| 118 | ERBB3 | 0.44107207 |
| 119 | PLK1 | 0.43753632 |
| 120 | FRK | 0.43441579 |
| 121 | PRKAA1 | 0.43392206 |
| 122 | DAPK3 | 0.43133014 |
| 123 | PRKCZ | 0.42909851 |
| 124 | CAMK1G | 0.42419922 |
| 125 | PAK4 | 0.40811089 |
| 126 | PRKACA | 0.40680079 |
| 127 | MAPK8 | 0.40576873 |
| 128 | PRKCH | 0.40502786 |
| 129 | TESK1 | 0.40075720 |
| 130 | ROCK2 | 0.39747938 |
| 131 | TYRO3 | 0.38050912 |
| 132 | PDK2 | 0.37814171 |
| 133 | CDK8 | 0.37457199 |
| 134 | DYRK1A | 0.36971021 |
| 135 | RAF1 | 0.35832712 |
| 136 | MAPKAPK5 | 0.35434892 |
| 137 | ADRBK2 | 0.34732870 |
| 138 | MST1R | 0.34032132 |
| 139 | TNK2 | 0.32685019 |
| 140 | MAP3K13 | 0.32264368 |
| 141 | CAMK1 | 0.32202884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 4.11663515 |
| 2 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.88980093 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.88447167 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 3.22821541 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 3.18375626 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.10242788 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.96965045 |
| 8 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.92895195 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.47090603 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.38192598 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.21239944 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 2.13357122 |
| 13 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.12069879 |
| 14 | Olfactory transduction_Homo sapiens_hsa04740 | 2.07142616 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 2.01123013 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.97796305 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.97101367 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.93529898 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.90155497 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.88154219 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.86618641 |
| 22 | Circadian entrainment_Homo sapiens_hsa04713 | 1.84017630 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.80478638 |
| 24 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.73762134 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.69901351 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.69444310 |
| 27 | Morphine addiction_Homo sapiens_hsa05032 | 1.69316862 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67598300 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.60918235 |
| 30 | Huntingtons disease_Homo sapiens_hsa05016 | 1.55463511 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48892972 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43465922 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.36274841 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34601505 |
| 35 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.34548585 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 1.34404132 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34274625 |
| 38 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.34041375 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.30106248 |
| 40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.29891714 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.22561328 |
| 42 | Circadian rhythm_Homo sapiens_hsa04710 | 1.20295321 |
| 43 | Gap junction_Homo sapiens_hsa04540 | 1.18624684 |
| 44 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.17395175 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16259202 |
| 46 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.16231687 |
| 47 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.14291981 |
| 48 | Cocaine addiction_Homo sapiens_hsa05030 | 1.13849685 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.13834203 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11317527 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.09972146 |
| 52 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.08615233 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.07849479 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04045722 |
| 55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.02977743 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 1.01326341 |
| 57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97828175 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90170766 |
| 59 | Phototransduction_Homo sapiens_hsa04744 | 0.88054291 |
| 60 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.83880576 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.82784342 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.81855921 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.81542744 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79573966 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.79154682 |
| 66 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78826401 |
| 67 | Melanogenesis_Homo sapiens_hsa04916 | 0.77247082 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72820957 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.72764880 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72260352 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.69439306 |
| 72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.69438773 |
| 73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.69211482 |
| 74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66865999 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66678229 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66510024 |
| 77 | Glioma_Homo sapiens_hsa05214 | 0.66042136 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65195474 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64710871 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64002172 |
| 81 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62949705 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62090865 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61808112 |
| 84 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.61772754 |
| 85 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.60352387 |
| 86 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.59785577 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58893833 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57789547 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57520344 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56346759 |
| 91 | Proteasome_Homo sapiens_hsa03050 | 0.56338644 |
| 92 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.55977018 |
| 93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55217525 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52293805 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50560263 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48540038 |
| 97 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47976497 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47698242 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.44854740 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.43164637 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43104926 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41712191 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41349531 |
| 104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41207190 |
| 105 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41110743 |
| 106 | Melanoma_Homo sapiens_hsa05218 | 0.40476333 |
| 107 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.40309601 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.39930475 |
| 109 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39284174 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.37900222 |
| 111 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37399658 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36969473 |
| 113 | Tight junction_Homo sapiens_hsa04530 | 0.36778931 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35972505 |
| 115 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35726566 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35721271 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34963075 |
| 118 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34830956 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.33376652 |
| 120 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.32999170 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32344910 |
| 122 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.31405955 |
| 123 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31296493 |
| 124 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.30367370 |
| 125 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30168546 |
| 126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30018300 |
| 127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28621613 |
| 128 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28306259 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28260354 |
| 130 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.28052593 |
| 131 | Alcoholism_Homo sapiens_hsa05034 | 0.27794408 |
| 132 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27223680 |
| 133 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26901003 |
| 134 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.23384935 |

